{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:05:38Z","timestamp":1764997538168,"version":"3.40.5"},"reference-count":43,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CGT"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>Duchenne Muscular Dystrophy (DMD) results in a deficiency of dystrophin expression\nin patient muscle fibers, leading to progressive muscle degeneration. Treatment of DMD has undertaken\ncurrent transformation with the advancement of novel gene therapy and molecular biology\ntechniques, which are secure, well-tolerated, and effective therapeutic approaches.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>DMD gene therapies have mainly focused on young DMD patients as in vivo animal\nmodel trials have been performed in 0\u20131-month DMD mice. However, it has not yet been answered\nhow micro-dystrophin encoding lentiviral treatment affects Dystrophin expression and DMD symptoms\nin 10-month mdx mice.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>We planned to integrate the micro-Dystrophin gene sequence into the muscle cells by viral\ntransfer, using micro-Dystrophin-encoding lentivirus to reduce the dystrophic pathology in late-stage\ndmd mice. The histopathological and physiological-functional regeneration activities of the lentiviralmicro-\nDystrophin gene therapy methods were compared, along with changes in temporal Dystrophin\nexpression and their functionality, toxicity, and gene expression level.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Here, we showed that the micro-dystrophin transgene transfers intramuscularly and intraperitoneally\nin late-stage dmd-mdx-4cv mice restored dystrophin expression in the skeletal and cardiac\nmuscle (p &lt;0.001). Furthermore, motor performance analysis, including hanging and tracking tests,\nimproved statistically significantly after the treatment (p &lt;0.05).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Consequently, this study suggests that patients in the late stages of muscular dystrophy\ncan benefit from lentiviral micro-dystrophin gene therapies to present an improvement in dystrophic\nmuscle pathology.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1566523223666230407091317","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T04:59:55Z","timestamp":1681102795000},"page":"304-315","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lentiviral Micro-dystrophin Gene Treatment into Late-stage mdx Mice\nfor Duchenne Muscular Dystrophy Disease"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6136-5033","authenticated-orcid":true,"given":"Selen Abanuz","family":"Eren","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Institute of Health Sciences, Acibadem Mehmet Ali Aydinlar\nUniversity, Istanbul, Turkey"},{"name":"Acibadem Labcell Cellular Therapy Laboratory, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4173-6634","authenticated-orcid":true,"given":"Cihan","family":"Tastan","sequence":"additional","affiliation":[{"name":"Acibadem Labcell Cellular Therapy Laboratory, Istanbul, Turkey"},{"name":"Molecular Biology\nand Genetics Department, Uskudar University, Istanbul, Turkey"},{"name":"Transgenic Cell Technologies and Epigenetic Application\nand Research Center (TRGENMER), Uskudar University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5370-6865","authenticated-orcid":true,"given":"Kevser Buse","family":"Karadeniz","sequence":"additional","affiliation":[{"name":"Acibadem Labcell Cellular Therapy Laboratory, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5159-4775","authenticated-orcid":true,"given":"Raife Dilek","family":"Turan","sequence":"additional","affiliation":[{"name":"Department of Genetic and Bioengineering,\nYeditepe University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1293-9520","authenticated-orcid":true,"given":"Didem","family":"Cakirsoy","sequence":"additional","affiliation":[{"name":"Acibadem Labcell Cellular Therapy Laboratory, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4725-3200","authenticated-orcid":true,"given":"Derya Dilek","family":"Kancagi","sequence":"additional","affiliation":[{"name":"Acibadem Labcell Cellular Therapy Laboratory, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8349-3629","authenticated-orcid":true,"given":"Sevdican Ustun","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Medical Biotechnology Department, Institute of Health Sciences,\nAcibadem Mehmet Ali Aydinlar University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9914-7122","authenticated-orcid":true,"given":"Mustafa","family":"Oztatlici","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Faculty of\nMedicine, Gaziantep Islam Science and Technology University, Gaziantep, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6749-9665","authenticated-orcid":true,"given":"Hulya","family":"Oztatlici","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology,\nFaculty of Medicine, Gaziantep University, Gaziantep, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1036-4046","authenticated-orcid":true,"given":"Samed","family":"Ozer","sequence":"additional","affiliation":[{"name":"Animal Application and Research Center,\nAcibadem Mehmet Ali Aydinlar University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3114-634X","authenticated-orcid":true,"given":"Gamze","family":"Tumentemur","sequence":"additional","affiliation":[{"name":"Vocational School of Health Services, Acibadem\nMehmet Ali Aydinlar University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8814-7351","authenticated-orcid":true,"given":"Ahmet Tar\u0131k","family":"Baykal","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Institute of Health Sciences, Acibadem Mehmet Ali Aydinlar\nUniversity, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4782-5355","authenticated-orcid":true,"given":"Ercument","family":"Ovali","sequence":"additional","affiliation":[{"name":"Acibadem Labcell Cellular Therapy Laboratory, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","volume":"24","author":"Mah J.K.","year":"2014","unstructured":"Mah J.K.; Korngut L.; Dykeman J.; Day L.; Pringsheim T.; Jette N.; A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 2014,24(6),482-491","journal-title":"Neuromuscul Disord"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"Bushby K.","year":"2010","unstructured":"Bushby K.; Finkel R.; Birnkrant D.J.; Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and pharmaco-logical and psychosocial management. Lancet Neurol 2010,9(1),77-93","journal-title":"Lancet Neurol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"Hoffman E.P.","year":"1987","unstructured":"Hoffman E.P.; Brown R.H.; Kunkel L.M.; Dystrophin: The protein product of the duchenne muscular dystrophy locus. Cell 1987,51(6),919-928","journal-title":"Cell"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1083\/jcb.122.4.809","volume":"122","author":"Ervasti J.M.","year":"1993","unstructured":"Ervasti J.M.; Campbell K.P.; A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993,122(4),809-823","journal-title":"J Cell Biol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/S0960-9822(01)00528-0","volume":"11","author":"Mariol M.C.","year":"2001","unstructured":"Mariol M.C.; S\u00e9galat L.; Muscular degeneration in the absence of dystrophin is a calcium-dependent process. Curr Biol 2001,11(21),1691-1694","journal-title":"Curr Biol"},{"key":"ref=6","first-page":"498","volume":"45","year":"1989","unstructured":"The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 1989,45(4),498-506","journal-title":"Am J Hum Genet"},{"key":"ref=7","first-page":"1","author":"Ervasti J.M.","year":"2006","unstructured":"Ervasti J.M.; Structure and function of the dystrophin-glycoprotein complex. In: Molecular Mechanisms of Muscular Dystrophies 2006,1-13","journal-title":"In: Molecular Mechanisms of Muscular Dystrophies"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/mus.1192","volume":"24","author":"Rando T.A.","year":"2001","unstructured":"Rando T.A.; The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve 2001,24(12),1575-1594","journal-title":"Muscle Nerve"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","volume":"90","author":"Petrof B.J.","year":"1993","unstructured":"Petrof B.J.; Shrager J.B.; Stedman H.H.; Kelly A.M.; Sweeney H.L.; Dystrophin protects the sarcolemma from stresses developed during mus-cle contraction. Proc Natl Acad Sci USA 1993,90(8),3710-3714","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2006.09.016","volume":"36","author":"Deconinck N.","year":"2007","unstructured":"Deconinck N.; Dan B.; Pathophysiology of duchenne muscular dystrophy: Current hypotheses. Pediatr Neurol 2007,36(1),1-7","journal-title":"Pediatr Neurol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1517\/21678707.2015.1088780","volume":"3","author":"Ramos J.","year":"2015","unstructured":"Ramos J.; Chamberlain J.S.; Gene therapy for Duchenne muscular dystrophy. Expert Opin Orphan Drugs 2015,3(11),1255-1266","journal-title":"Expert Opin Orphan Drugs"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/nm.3990","volume":"21","author":"Dumont N.A.","year":"2015","unstructured":"Dumont N.A.; Wang Y.X.; von Maltzahn J.; Dystrophin expression in muscle stem cells regulates their polarity and asymmetric divi-sion. Nat Med 2015,21(12),1455-1463","journal-title":"Nat Med"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"Counsell J.R.","year":"2017","unstructured":"Counsell J.R.; Asgarian Z.; Meng J.; Ferrer V.; Vink C.A.; Howe S.J.; Lentiviral vectors can be used for full-length dystrophin gene therapy. Sci Rep 2017,7(1),1-10","journal-title":"Sci Rep"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.1182\/blood-2009-04-214569","volume":"114","author":"Annoni A.","year":"2009","unstructured":"Annoni A.; Brown B.D.; Cantore A.; Sergi L.S.; Naldini L.; Roncarolo M.G.; In vivo delivery of a microRNA-regulated transgene induces anti-gen-specific regulatory T cells and promotes immunologic tolerance. Blood 2009,114(25),5152-5161","journal-title":"Blood"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1089\/hum.2008.058","volume":"19","author":"Bostick B.","year":"2008","unstructured":"Bostick B.; Yue Y.; Lai Y.; Long C.; Li D.; Duan D.; Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electro-cardiographic abnormalities in mdx mice. Hum Gene Ther 2008,19(8),851-856","journal-title":"Hum Gene Ther"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1172\/JCI36612","volume":"119","author":"Lai Y.","year":"2009","unstructured":"Lai Y.; Thomas G.D.; Yue Y.; Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest 2009,119(3),624-635","journal-title":"J Clin Invest"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mus.21873","volume":"43","author":"Shin J.H.","year":"2011","unstructured":"Shin J.H.; Hakim C.H.; Zhang K.; Duan D.; Genotyping mdx, mdx3cv, and mdx4cv mice by primer competition polymerase chain reaction. Muscle Nerve 2011,43(2),283-286","journal-title":"Muscle Nerve"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ar.1092420109","volume":"242","author":"Lefaucheur J.P.","year":"1995","unstructured":"Lefaucheur J.P.; Pastoret C.; Sebille A.; Phenotype of dystrophinopathy in old mdx mice. Anat Rec 1995,242(1),70-76","journal-title":"Anat Rec"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0022-510X(94)00276-T","volume":"129","author":"Pastoret C.","year":"1995","unstructured":"Pastoret C.; Sebille A.; mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci 1995,129(2),97-105","journal-title":"J Neurol Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1469-7793.2001.00591.x","volume":"535","author":"Lynch G.S.","year":"2001","unstructured":"Lynch G.S.; Hinkle R.T.; Chamberlain J.S.; Brooks S.V.; Faulkner J.A.; Force and power output of fast and slow skeletal muscles from mdx mice 6\u201028 months old. J Physiol 2001,535(2),591-600","journal-title":"J Physiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1093\/hmg\/ddr433","volume":"20","author":"Judge L.M.","year":"2011","unstructured":"Judge L.M.; Arnett A.L.H.; Banks G.B.; Chamberlain J.S.; Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice. Hum Mol Genet 2011,20(24),4978-4990","journal-title":"Hum Mol Genet"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.nmd.2005.12.007","volume":"16","author":"Gaedigk R.","year":"2006","unstructured":"Gaedigk R.; Law D.J.; Fitzgerald-Gustafson K.M.; Improvement in survival and muscle function in an mdx\/utrn\u2212\/\u2212 double mutant mouse using a human retinal dystrophin transgene. Neuromuscul Disord 2006,16(3),192-203","journal-title":"Neuromuscul Disord"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10974-015-9406-4","volume":"36","author":"Manning J.","year":"2015","unstructured":"Manning J.; O\u2019Malley D.; What has the mdx mouse model of duchenne muscular dystrophy contributed to our understanding of this dis-ease? J Muscle Res Cell Motil 2015,36(2),155-167","journal-title":"J Muscle Res Cell Motil"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00314217","volume":"236","author":"Cros D.","year":"1989","unstructured":"Cros D.; Harnden P.; Pellissier J.F.; Serratrice G.; Muscle hypertrophy in Duchenne muscular dystrophy. J Neurol 1989,236(1),43-47","journal-title":"J Neurol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/mus.21341","volume":"40","author":"Marques M.J.","year":"2009","unstructured":"Marques M.J.; Oggiam D.S.; Barbin I.C.C.; Ferretti R.; Santo Neto H.; Long-term therapy with deflazacort decreases myocardial fibrosis in mdx mice. Muscle Nerve 2009,40(3),466-468","journal-title":"Muscle Nerve"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1093\/hmg\/ddn151","volume":"17","author":"Kimura E.","year":"2008","unstructured":"Kimura E.; Han J.J.; Li S.; Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy. Hum Mol Genet 2008,17(16),2507-2517","journal-title":"Hum Mol Genet"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1261\/rna.2192803","volume":"9","author":"Stewart S.A.","year":"2003","unstructured":"Stewart S.A.; Dykxhoorn D.M.; Palliser D.; Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 2003,9(4),493-501","journal-title":"RNA"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4274\/tjh.galenos.2020.2020.0070","volume":"37","author":"Ta\u015ftan C.","year":"2020","unstructured":"Ta\u015ftan C.; Kan\u00e7a\u011f\u0131 D.D.; Turan R.D.; Preclinical assessment of efficacy and safety analysis of car-t cells (Isikok-19) targeting cd19-expressing b-cells for the first turkish academic clinical trial with relapsed\/refractory all and nhl patients. Turk J Haematol 2020,37(4),234-247","journal-title":"Turk J Haematol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1089\/hgtb.2017.078","volume":"28","author":"Zhao Y.","year":"2017","unstructured":"Zhao Y.; Stepto H.; Schneider C.K.; Development of the first world health organization lentiviral vector standard: Toward the production control and standardization of lentivirus-based gene therapy products. Hum Gene Ther Methods 2017,28(4),205-214","journal-title":"Hum Gene Ther Methods"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/mt.2010.278","volume":"19","author":"Cornetta K.","year":"2011","unstructured":"Cornetta K.; Yao J.; Jasti A.; Replication-competent lentivirus analysis of clinical grade vector products. Mol Ther 2011,19(3),557-566","journal-title":"Mol Ther"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/mt.2012.150","volume":"20","author":"Agudo J.","year":"2012","unstructured":"Agudo J.; Ruzo A.; Kitur K.; Sachidanandam R.; Blander J.M.; Brown B.D.; A TLR and non-TLR mediated innate response to lentiviruses restricts hepatocyte entry and can be ameliorated by pharmacological blockade. Mol Ther 2012,20(12),2257-2267","journal-title":"Mol Ther"},{"key":"ref=32","author":"Aartsma-Rus A.","year":"2014","unstructured":"Aartsma-Rus A.; van Putten M.; Assessing functional performance in the mdx mouse model. J Vis Exp 2014","journal-title":"J Vis Exp"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/mt.2008.23","volume":"16","author":"Kawano R.","year":"2008","unstructured":"Kawano R.; Ishizaki M.; Maeda Y.; Uchida Y.; Kimura E.; Uchino M.; Transduction of full-length dystrophin to multiple skeletal muscles improves motor performance and life span in utrophin\/dystrophin double knockout mice. Mol Ther 2008,16(5),825-831","journal-title":"Mol Ther"},{"key":"ref=34","first-page":"56772","volume":"130","author":"Gibbs E.M.","year":"2017","unstructured":"Gibbs E.M.; Crosbie-Watson R.H.; A simple and low-cost assay for measuring ambulation in mouse models of muscular dystrophy. J Vis Exp 2017,130,56772","journal-title":"J Vis Exp"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/mt.2008.186","volume":"16","author":"Foster H.","year":"2008","unstructured":"Foster H.; Sharp P.S.; Athanasopoulos T.; Codon and mRNA sequence optimization of microdystrophin transgenes improves expres-sion and physiological outcome in dystrophic mdx mice following AAV2\/8 gene transfer. Mol Ther 2008,16(11),1825-1832","journal-title":"Mol Ther"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0022-510X(91)90068-I","volume":"102","author":"Zatz M.","year":"1991","unstructured":"Zatz M.; Rapaport D.; Vainzof M.; Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in duchenne (DMD) as compared with becker (BMD) muscular dystrophy. J Neurol Sci 1991,102(2),190-196","journal-title":"J Neurol Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1089\/hum.2018.012","volume":"29","author":"Duan D.","year":"2018","unstructured":"Duan D.; Micro-dystrophin gene therapy goes systemic in duchenne muscular dystrophy patients. Hum Gene Ther 2018,29(7),733-736","journal-title":"Hum Gene Ther"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1023\/A:1014587918367","volume":"22","author":"Dellorusso C.","year":"2001","unstructured":"Dellorusso C.; Crawford R.W.; Chamberlain J.S.; Brooks S.V.; Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury. J Muscle Res Cell Motil 2001,22(5),467-475","journal-title":"J Muscle Res Cell Motil"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e21628","DOI":"10.1096\/fj.202100057RR","volume":"35","author":"Chu X.","year":"2021","unstructured":"Chu X.; Li J.; Qiao C.; Long\u2010term effect of human mini\u2010dystrophin in transgenic mdx mice improves muscle physiological function. FASEB J 2021,35(6),e21628","journal-title":"FASEB J"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/jor.22236","volume":"31","author":"Isaac C.","year":"2013","unstructured":"Isaac C.; Wright A.; Usas A.; Dystrophin and utrophin \u201cdouble knockout\u201d dystrophic mice exhibit a spectrum of degenerative mus-culoskeletal abnormalities. J Orthop Res 2013,31(3),343-349","journal-title":"J Orthop Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.memsci.2015.11.021","volume":"503","author":"Wang J.W.","year":"2016","unstructured":"Wang J.W.; Song M.; He Y.H.; Gong H.R.; Stability, adsorption, and diffusion of hydrogen in Pd3Ag phases. J Membr Sci 2016,503,124-131","journal-title":"J Membr Sci"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","volume":"351","author":"Long C.","year":"2016","unstructured":"Long C.; Amoasii L.; Mireault A.A.; McAnally J.R.; Li H.; Sanchez-Ortiz E.; Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science 2016,351(6271),400-403","journal-title":"Science"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1083\/jcb.150.6.1399","volume":"150","author":"Crawford G.E.","year":"2000","unstructured":"Crawford G.E.; Faulkner J.A.; Crosbie R.H.; Campbell K.P.; Froehner S.C.; Chamberlain J.S.; Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain. J Cell Biol 2000,150(6),1399-1410","journal-title":"J Cell Biol"}],"container-title":["Current Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566523223666230407091317","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215523\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566523223666230407091317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T12:15:51Z","timestamp":1693570551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215523\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566523223666230407091317","relation":{},"ISSN":["1566-5232"],"issn-type":[{"type":"print","value":"1566-5232"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-08-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}